Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1995 Jun;95(6):2938–2944. doi: 10.1172/JCI118001

Protein kinase C is increased in the liver of humans and rats with non-insulin-dependent diabetes mellitus: an alteration not due to hyperglycemia.

R V Considine 1, M R Nyce 1, L E Allen 1, L M Morales 1, S Triester 1, J Serrano 1, J Colberg 1, S Lanza-Jacoby 1, J F Caro 1
PMCID: PMC295982  PMID: 7769136

Abstract

We tested the hypothesis that liver protein kinase C (PKC) is increased in non-insulin-dependent diabetes mellitus (NIDDM). To this end we examined the distribution of PKC isozymes in liver biopsies from obese individuals with and without NIDDM and in lean controls. PKC isozymes alpha, beta, epsilon and zeta were detected by immunoblotting in both the cytosol and membrane fractions. Isozymes gamma and delta were not detected. There was a significant increase in immunodetectable PKC-alpha (twofold), -epsilon (threefold), and -zeta (twofold) in the membrane fraction isolated from obese subjects with NIDDM compared with the lean controls. In obese subjects without NIDDM, the amount of membrane PKC isozymes was not different from the other two groups. We next sought an animal model where this observation could be studied further. The Zucker diabetic fatty rat offered such a model system. Immunodetectable membrane PKC-alpha, -beta, -epsilon, and -zeta were significantly increased when compared with both the lean and obese controls. The increase in immunodetectable PKC protein correlated with a 40% elevation in the activity of PKC at the membrane. Normalization of circulating glucose in the rat model by either insulin or phlorizin treatment did not result in a reduction in membrane PKC isozyme protein or kinase activity. Further, phlorizin treatment did not improve insulin receptor autophosphorylation nor did the treatment lower liver diacylglycerol. We conclude that liver PKC is increased in NIDDM, a change that is not secondary to hyperglycemia. It is possible that PKC-mediated phosphorylation of some component in the insulin signaling cascade contributes to the insulin resistance observed in NIDDM.

Full text

PDF
2938

Images in this article

2940Image
on p.2940
2940Image
on p.2940
2942Image
on p.2942

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson C. M., Olefsky J. M. Phorbol ester-mediated protein kinase C interaction with wild-type and COOH-terminal truncated insulin receptors. J Biol Chem. 1991 Nov 15;266(32):21760–21764. [PubMed] [Google Scholar]
  2. Arner P., Pollare T., Lithell H., Livingston J. N. Defective insulin receptor tyrosine kinase in human skeletal muscle in obesity and type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1987 Jun;30(6):437–440. doi: 10.1007/BF00292549. [DOI] [PubMed] [Google Scholar]
  3. Arnold T. P., Standaert M. L., Hernandez H., Watson J., Mischak H., Kazanietz M. G., Zhao L., Cooper D. R., Farese R. V. Effects of insulin and phorbol esters on MARCKS (myristoylated alanine-rich C-kinase substrate) phosphorylation (and other parameters of protein kinase C activation) in rat adipocytes, rat soleus muscle and BC3H-1 myocytes. Biochem J. 1993 Oct 1;295(Pt 1):155–164. doi: 10.1042/bj2950155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. BLIGH E. G., DYER W. J. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959 Aug;37(8):911–917. doi: 10.1139/o59-099. [DOI] [PubMed] [Google Scholar]
  5. Bollag G. E., Roth R. A., Beaudoin J., Mochly-Rosen D., Koshland D. E., Jr Protein kinase C directly phosphorylates the insulin receptor in vitro and reduces its protein-tyrosine kinase activity. Proc Natl Acad Sci U S A. 1986 Aug;83(16):5822–5824. doi: 10.1073/pnas.83.16.5822. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Caro J. F., Dohm L. G., Pories W. J., Sinha M. K. Cellular alterations in liver, skeletal muscle, and adipose tissue responsible for insulin resistance in obesity and type II diabetes. Diabetes Metab Rev. 1989 Dec;5(8):665–689. doi: 10.1002/dmr.5610050804. [DOI] [PubMed] [Google Scholar]
  7. Caro J. F., Ittoop O., Pories W. J., Meelheim D., Flickinger E. G., Thomas F., Jenquin M., Silverman J. F., Khazanie P. G., Sinha M. K. Studies on the mechanism of insulin resistance in the liver from humans with noninsulin-dependent diabetes. Insulin action and binding in isolated hepatocytes, insulin receptor structure, and kinase activity. J Clin Invest. 1986 Jul;78(1):249–258. doi: 10.1172/JCI112558. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Caro J. F., Jenquin M., Long S. Effects of phorbol esters on insulin receptor function and insulin action in hepatocytes: evidence for heterogeneity. Mol Cell Biochem. 1992 Feb 12;109(2):115–118. doi: 10.1007/BF00229764. [DOI] [PubMed] [Google Scholar]
  9. Caro J. F., Sinha M. K., Raju S. M., Ittoop O., Pories W. J., Flickinger E. G., Meelheim D., Dohm G. L. Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes. J Clin Invest. 1987 May;79(5):1330–1337. doi: 10.1172/JCI112958. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Chin J. E., Dickens M., Tavare J. M., Roth R. A. Overexpression of protein kinase C isoenzymes alpha, beta I, gamma, and epsilon in cells overexpressing the insulin receptor. Effects on receptor phosphorylation and signaling. J Biol Chem. 1993 Mar 25;268(9):6338–6347. [PubMed] [Google Scholar]
  11. Coghlan M. P., Siddle K. Phorbol esters induce insulin receptor phosphorylation in transfected fibroblasts without affecting tyrosine kinase activity. Biochem Biophys Res Commun. 1993 May 28;193(1):371–377. doi: 10.1006/bbrc.1993.1633. [DOI] [PubMed] [Google Scholar]
  12. Cooper D. R., Hernandez H., Kuo J. Y., Farese R. V. Insulin increases the synthesis of phospholipid and diacylglycerol and protein kinase C activity in rat hepatocytes. Arch Biochem Biophys. 1990 Feb 1;276(2):486–494. doi: 10.1016/0003-9861(90)90749-o. [DOI] [PubMed] [Google Scholar]
  13. Craven P. A., DeRubertis F. R. Protein kinase C is activated in glomeruli from streptozotocin diabetic rats. Possible mediation by glucose. J Clin Invest. 1989 May;83(5):1667–1675. doi: 10.1172/JCI114066. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. DeFronzo R. A., Bonadonna R. C., Ferrannini E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care. 1992 Mar;15(3):318–368. doi: 10.2337/diacare.15.3.318. [DOI] [PubMed] [Google Scholar]
  15. Draznin B. Cytosolic calcium and insulin resistance. Am J Kidney Dis. 1993 Jun;21(6 Suppl 3):32–38. doi: 10.1016/0272-6386(93)70122-f. [DOI] [PubMed] [Google Scholar]
  16. Freidenberg G. R., Henry R. R., Klein H. H., Reichart D. R., Olefsky J. M. Decreased kinase activity of insulin receptors from adipocytes of non-insulin-dependent diabetic subjects. J Clin Invest. 1987 Jan;79(1):240–250. doi: 10.1172/JCI112789. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Freidenberg G. R., Reichart D., Olefsky J. M., Henry R. R. Reversibility of defective adipocyte insulin receptor kinase activity in non-insulin-dependent diabetes mellitus. Effect of weight loss. J Clin Invest. 1988 Oct;82(4):1398–1406. doi: 10.1172/JCI113744. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Ha K. S., Exton J. H. Differential translocation of protein kinase C isozymes by thrombin and platelet-derived growth factor. A possible function for phosphatidylcholine-derived diacylglycerol. J Biol Chem. 1993 May 15;268(14):10534–10539. [PubMed] [Google Scholar]
  19. Hotamisligil G. S., Budavari A., Murray D., Spiegelman B. M. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha. J Clin Invest. 1994 Oct;94(4):1543–1549. doi: 10.1172/JCI117495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Hurrell D. G., Pedersen O., Kahn C. R. Alterations in the hepatic insulin receptor kinase in genetic and acquired obesity in rats. Endocrinology. 1989 Nov;125(5):2454–2462. doi: 10.1210/endo-125-5-2454. [DOI] [PubMed] [Google Scholar]
  21. Inoguchi T., Battan R., Handler E., Sportsman J. R., Heath W., King G. L. Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):11059–11063. doi: 10.1073/pnas.89.22.11059. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Kahn B. B., Shulman G. I., DeFronzo R. A., Cushman S. W., Rossetti L. Normalization of blood glucose in diabetic rats with phlorizin treatment reverses insulin-resistant glucose transport in adipose cells without restoring glucose transporter gene expression. J Clin Invest. 1991 Feb;87(2):561–570. doi: 10.1172/JCI115031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Kahn C. R., White M. F. The insulin receptor and the molecular mechanism of insulin action. J Clin Invest. 1988 Oct;82(4):1151–1156. doi: 10.1172/JCI113711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Kanety H., Moshe S., Shafrir E., Lunenfeld B., Karasik A. Hyperinsulinemia induces a reversible impairment in insulin receptor function leading to diabetes in the sand rat model of non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A. 1994 Mar 1;91(5):1853–1857. doi: 10.1073/pnas.91.5.1853. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Karasik A., Rothenberg P. L., Yamada K., White M. F., Kahn C. R. Increased protein kinase C activity is linked to reduced insulin receptor autophosphorylation in liver of starved rats. J Biol Chem. 1990 Jun 25;265(18):10226–10231. [PubMed] [Google Scholar]
  26. Lewis R. E., Cao L., Perregaux D., Czech M. P. Threonine 1336 of the human insulin receptor is a major target for phosphorylation by protein kinase C. Biochemistry. 1990 Feb 20;29(7):1807–1813. doi: 10.1021/bi00459a020. [DOI] [PubMed] [Google Scholar]
  27. Liu F., Roth R. A. Insulin-stimulated tyrosine phosphorylation of protein kinase C alpha: evidence for direct interaction of the insulin receptor and protein kinase C in cells. Biochem Biophys Res Commun. 1994 May 16;200(3):1570–1577. doi: 10.1006/bbrc.1994.1630. [DOI] [PubMed] [Google Scholar]
  28. Müller H. K., Kellerer M., Ermel B., Mühlhöfer A., Obermaier-Kusser B., Vogt B., Häring H. U. Prevention by protein kinase C inhibitors of glucose-induced insulin-receptor tyrosine kinase resistance in rat fat cells. Diabetes. 1991 Nov;40(11):1440–1448. doi: 10.2337/diab.40.11.1440. [DOI] [PubMed] [Google Scholar]
  29. Nivet V., Clot J. P., Do X. T., Barrault V., Prélot M., Durand D. Evidence that growth hormone stimulates protein kinase C activity in isolated rat hepatocytes. Metabolism. 1993 Oct;42(10):1291–1295. doi: 10.1016/0026-0495(93)90127-a. [DOI] [PubMed] [Google Scholar]
  30. Obermaier-Kusser B., White M. F., Pongratz D. E., Su Z., Ermel B., Muhlbacher C., Haring H. U. A defective intramolecular autoactivation cascade may cause the reduced kinase activity of the skeletal muscle insulin receptor from patients with non-insulin-dependent diabetes mellitus. J Biol Chem. 1989 Jun 5;264(16):9497–9504. [PubMed] [Google Scholar]
  31. Preiss J., Loomis C. R., Bishop W. R., Stein R., Niedel J. E., Bell R. M. Quantitative measurement of sn-1,2-diacylglycerols present in platelets, hepatocytes, and ras- and sis-transformed normal rat kidney cells. J Biol Chem. 1986 Jul 5;261(19):8597–8600. [PubMed] [Google Scholar]
  32. Quentmeier A., Daneschmand H., Klein H., Unthan-Fechner K., Probst I. Insulin-mimetic actions of phorbol ester in cultured adult rat hepatocytes. Lack of phorbol-ester-elicited inhibition of the insulin signal. Biochem J. 1993 Jan 15;289(Pt 2):549–555. doi: 10.1042/bj2890549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Rossetti L., Smith D., Shulman G. I., Papachristou D., DeFronzo R. A. Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats. J Clin Invest. 1987 May;79(5):1510–1515. doi: 10.1172/JCI112981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Sinha M. K., Pories W. J., Flickinger E. G., Meelheim D., Caro J. F. Insulin-receptor kinase activity of adipose tissue from morbidly obese humans with and without NIDDM. Diabetes. 1987 May;36(5):620–625. doi: 10.2337/diab.36.5.620. [DOI] [PubMed] [Google Scholar]
  35. Takayama S., White M. F., Kahn C. R. Phorbol ester-induced serine phosphorylation of the insulin receptor decreases its tyrosine kinase activity. J Biol Chem. 1988 Mar 5;263(7):3440–3447. [PubMed] [Google Scholar]
  36. Takayama S., White M. F., Lauris V., Kahn C. R. Phorbol esters modulate insulin receptor phosphorylation and insulin action in cultured hepatoma cells. Proc Natl Acad Sci U S A. 1984 Dec;81(24):7797–7801. doi: 10.1073/pnas.81.24.7797. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Tang E. Y., Parker P. J., Beattie J., Houslay M. D. Diabetes induces selective alterations in the expression of protein kinase C isoforms in hepatocytes. FEBS Lett. 1993 Jul 12;326(1-3):117–123. doi: 10.1016/0014-5793(93)81774-t. [DOI] [PubMed] [Google Scholar]
  38. Thakker J. K., DiMarchi R., MacDonald K., Caro J. F. Effect of insulin and insulin-like growth factors I and II on phosphatidylinositol and phosphatidylinositol 4,5-bisphosphate breakdown in liver from humans with and without type II diabetes. J Biol Chem. 1989 May 5;264(13):7169–7175. [PubMed] [Google Scholar]
  39. Turinsky J., O'Sullivan D. M., Bayly B. P. 1,2-Diacylglycerol and ceramide levels in insulin-resistant tissues of the rat in vivo. J Biol Chem. 1990 Oct 5;265(28):16880–16885. [PubMed] [Google Scholar]
  40. Wetsel W. C., Khan W. A., Merchenthaler I., Rivera H., Halpern A. E., Phung H. M., Negro-Vilar A., Hannun Y. A. Tissue and cellular distribution of the extended family of protein kinase C isoenzymes. J Cell Biol. 1992 Apr;117(1):121–133. doi: 10.1083/jcb.117.1.121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Wolf B. A., Williamson J. R., Easom R. A., Chang K., Sherman W. R., Turk J. Diacylglycerol accumulation and microvascular abnormalities induced by elevated glucose levels. J Clin Invest. 1991 Jan;87(1):31–38. doi: 10.1172/JCI114988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Zachayus J. L., Cherqui G., Plas C. Protein kinase C and insulin receptor beta-subunit serine phosphorylation in cultured foetal rat hepatocytes. Mol Cell Endocrinol. 1994 Oct;105(1):11–20. doi: 10.1016/0303-7207(94)90030-2. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES